Regional differences in clear cell metastatic renal cell carcinoma patients across the USA
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Bibliographic citation
-
In: World Journal of Urology, 41, S. 2991-3000
- Event
-
Veröffentlichung
- (where)
-
Augsburg
- (who)
-
Universität Augsburg
- (when)
-
2023
- Event
-
Veröffentlichung
- (who)
-
Springer Science and Business Media LLC
- (when)
-
2023
- Creator
-
Scheipner, Lukas
Tappero, Stefano
Piccinelli, Mattia Luca
Barletta, Francesco
Cano Garcia, Cristina
Incesu, Reha-Baris
Morra, Simone
Baudo, Andrea
Tian, Zhe
Saad, Fred
Shariat, Shahrokh F.
Terrone, Carlo
De Cobelli, Ottavio
Briganti, Alberto
Chun, Felix K. H.
Tilki, Derya
Longo, Nicola
Carmignani, Luca
Pichler, Martin
Hutterer, Georg
Ahyai, Sascha
Karakiewicz, Pierre I.
- DOI
-
10.1007/s00345-023-04589-4
- URN
-
urn:nbn:de:bvb:384-opus4-1087817
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:27 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Scheipner, Lukas
- Tappero, Stefano
- Piccinelli, Mattia Luca
- Barletta, Francesco
- Cano Garcia, Cristina
- Incesu, Reha-Baris
- Morra, Simone
- Baudo, Andrea
- Tian, Zhe
- Saad, Fred
- Shariat, Shahrokh F.
- Terrone, Carlo
- De Cobelli, Ottavio
- Briganti, Alberto
- Chun, Felix K. H.
- Tilki, Derya
- Longo, Nicola
- Carmignani, Luca
- Pichler, Martin
- Hutterer, Georg
- Ahyai, Sascha
- Karakiewicz, Pierre I.
- Universität Augsburg
- Springer Science and Business Media LLC
Time of origin
- 2023
Other Objects (12)
So finden Sie den passenden Coach : der Wegweiser zum Erfolg - Antworten, die das Internet nicht gibt
PD-1 and PD-L1 inhibitors after platinum-based chemotherapy or in first-line therapy in cisplatin-ineligible patients : Dramatic improvement of prognosis and overall survival after decades of hopelessness in patients with metastatic urothelial cancer
Current concepts of non-coding RNAs in the pathogenesis of non-clear cell renal cell carcinoma
Enhancing oncogenic signaling to kill cancer cells
Cost-effectiveness analysis of the use of immunotherapy in metastatic solid tumours in Austria by applying the ESMO-magnitude of clinical benefit scale (ESMO-MCBS) version 1.1
Best of ASCO 2022: bladder cancer
The role of microRNAs in breast cancer stem cells
Prostatakrebs : Vorbeugung, Diagnose; Therapie
Medical practice and placebo response: an inseparable bond?
Nonmuscle invasive urothelial cancer— Bacillus Calmette–Guérin instillation or checkpoint inhibitor immunotherapy?
Association of patients’ sex with treatment outcomes after intravesical bacillus Calmette–Guérin immunotherapy for T1G3/HG bladder cancer
Evidence and emerging trends in local therapy for metastatic hormone-sensitive prostate cancer: a narrative review
So finden Sie den passenden Coach : der Wegweiser zum Erfolg - Antworten, die das Internet nicht gibt
PD-1 and PD-L1 inhibitors after platinum-based chemotherapy or in first-line therapy in cisplatin-ineligible patients : Dramatic improvement of prognosis and overall survival after decades of hopelessness in patients with metastatic urothelial cancer
Current concepts of non-coding RNAs in the pathogenesis of non-clear cell renal cell carcinoma
Enhancing oncogenic signaling to kill cancer cells
Cost-effectiveness analysis of the use of immunotherapy in metastatic solid tumours in Austria by applying the ESMO-magnitude of clinical benefit scale (ESMO-MCBS) version 1.1
Best of ASCO 2022: bladder cancer
The role of microRNAs in breast cancer stem cells
Prostatakrebs : Vorbeugung, Diagnose; Therapie
Medical practice and placebo response: an inseparable bond?
Nonmuscle invasive urothelial cancer— Bacillus Calmette–Guérin instillation or checkpoint inhibitor immunotherapy?
Association of patients’ sex with treatment outcomes after intravesical bacillus Calmette–Guérin immunotherapy for T1G3/HG bladder cancer
Evidence and emerging trends in local therapy for metastatic hormone-sensitive prostate cancer: a narrative review
So finden Sie den passenden Coach : der Wegweiser zum Erfolg - Antworten, die das Internet nicht gibt
PD-1 and PD-L1 inhibitors after platinum-based chemotherapy or in first-line therapy in cisplatin-ineligible patients : Dramatic improvement of prognosis and overall survival after decades of hopelessness in patients with metastatic urothelial cancer
Current concepts of non-coding RNAs in the pathogenesis of non-clear cell renal cell carcinoma
Enhancing oncogenic signaling to kill cancer cells
Cost-effectiveness analysis of the use of immunotherapy in metastatic solid tumours in Austria by applying the ESMO-magnitude of clinical benefit scale (ESMO-MCBS) version 1.1
Best of ASCO 2022: bladder cancer
The role of microRNAs in breast cancer stem cells
Prostatakrebs : Vorbeugung, Diagnose; Therapie
Medical practice and placebo response: an inseparable bond?
Nonmuscle invasive urothelial cancer— Bacillus Calmette–Guérin instillation or checkpoint inhibitor immunotherapy?
Association of patients’ sex with treatment outcomes after intravesical bacillus Calmette–Guérin immunotherapy for T1G3/HG bladder cancer